Isis Pharmaceuticals Becomes Ionis Pharmaceuticals Over ‘ISIS’ Concerns

Business, News

California based biotech company Isis Pharmaceuticals had been contemplating a name chance since the Paris terror attacks that took place in November. The company was wary of people and media wrongly associating them with the terrorist group ‘ISIS’. Company’s associate director of corporate communications Dr. Amy Williford said, “We wanted to have a good feeling associated with the company.” She mentioned that employee safety was a motivating factor behind the decision as well since scientists working with Ionis often travel to other countries.

Isis Pharma

Isis/Ionis was founded 30 years back and it deals in drugs for rare and critical diseases. Dr. Williford confirmed that the company will move to a new domain called ionispharma.com and will change its stock market ticker to ‘IONS’. Documents bearing the name of Isis will also be amended. Last month the VP of Corporate Communications D. Wade Walke hinted at the company looking for a new identity.

Please follow and like us:
Soumyajit DasMazumdar on FacebookSoumyajit DasMazumdar on LinkedinSoumyajit DasMazumdar on Twitter
Soumyajit DasMazumdar
Soumyajit is an SAP technical consultant with a flair for writing. An avid blog reader, he started off with a free WordPress blog and slowly moved to his own personal news and blog site. Apart from writing he loves reading books, playing table tennis and long bike trips. He is currently trying to learn playing guitar and failing miserably.

Leave a Reply